Changmao Biochemical Engineering Balance Sheet Health
Financial Health criteria checks 3/6
Changmao Biochemical Engineering has a total shareholder equity of CN¥651.6M and total debt of CN¥492.6M, which brings its debt-to-equity ratio to 75.6%. Its total assets and total liabilities are CN¥1.2B and CN¥590.9M respectively. Changmao Biochemical Engineering's EBIT is CN¥21.6M making its interest coverage ratio 3.3. It has cash and short-term investments of CN¥96.6M.
Key information
75.6%
Debt to equity ratio
CN¥492.61m
Debt
Interest coverage ratio | 3.3x |
Cash | CN¥96.56m |
Equity | CN¥651.59m |
Total liabilities | CN¥590.91m |
Total assets | CN¥1.24b |
Recent financial health updates
No updates
Recent updates
Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist
Aug 02Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled
Nov 18We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability
Apr 28Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns
Aug 03Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital
May 04Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield
Feb 23Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?
Jan 26A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary
Dec 02Financial Position Analysis
Short Term Liabilities: 954's short term assets (CN¥338.3M) exceed its short term liabilities (CN¥325.2M).
Long Term Liabilities: 954's short term assets (CN¥338.3M) exceed its long term liabilities (CN¥265.7M).
Debt to Equity History and Analysis
Debt Level: 954's net debt to equity ratio (60.8%) is considered high.
Reducing Debt: 954's debt to equity ratio has increased from 6.2% to 75.6% over the past 5 years.
Debt Coverage: 954's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 954's interest payments on its debt are well covered by EBIT (3.3x coverage).